RESTORIL 7.5 mg/1 (Temazepam CAPSULE) 7.5 mg/1

RESTORIL 7.5 mg capsules contain temazepam, a medication used to aid sleep. This prescription-only treatment is designed to help individuals struggling with insomnia. RESTORIL is manufactured by SpecGx LLC in the USA.

Strength

7.5 mg/1

Pack Size

100 CAPSULE in 1 BOTTLE (0406-9915-01)

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RESTORIL 7.5 mg capsules are commonly used to treat insomnia, helping individuals fall asleep faster and improve sleep quality. Temazepam, the active ingredient, works by affecting certain chemicals in the brain to promote relaxation and sleep. RESTORIL is intended for short-term use to address sleep disturbances.

Side Effects

Common effects of RESTORIL 7.5 mg capsules may include drowsiness, dizziness, and a feeling of relaxation. Some users may experience mild side effects such as headache, nausea, or blurred vision. These effects vary among individuals and typically subside as the body adjusts to the medication.

Precautions & Warnings

RESTORIL 7.5 mg capsules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Avoid activities that require alertness, such as driving or operating machinery, until you know how the medication affects you.

Avoid Interactions

RESTORIL 7.5 mg capsules may interact with other medications, including alcohol, antidepressants, and sedatives. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

RESTORIL is used to treat insomnia, helping individuals fall asleep faster and improve sleep quality.

RESTORIL 7.5 mg capsules are taken orally, typically before bedtime. Follow the dosage instructions provided by your healthcare professional.

Common side effects may include drowsiness, dizziness, headache, nausea, and blurred vision.

It is generally advised to avoid alcohol while taking RESTORIL, as it may increase the risk of side effects.

RESTORIL is typically intended for short-term use. Long-term use should be discussed with a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.